FerroptoCure Inc. Selected for Vision Award at 2025 FemCareTech Conference
FerroptoCurehttps://www.nttdata.com/jp/ja/lineup/hcclab/bizcon202503
FerroptoCure Inc, is happy to announce that Yuji Otsuki was awarded the Vision Award at the FemCareTech 2025 Conference! Dr. Otsuki and FerroptoCure is committed to treating Triple Negative Breast Cancer with our novel ferroptosis-based therapeutics.
